News Sentiment

BLFS sentiment intelligence

BioLife Solutions Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 28.18 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+0.2% over one week, +8.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

BioLife Solutions (NASDAQ: BLFS) EVP has 516 shares withheld for taxes

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 0.2% Price digesting
Trend fit Trend active 8.0% over four weeks
Fair value 30.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 33
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
TradingView 8
Market source 6
Simply Wall Street 5
Investing.com 5
GuruFocus 3
PR Newswire 3
dars.gov.et 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 17
Balance sheet 2
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50
Stock Titan Direct company coverage

BioLife Solutions (NASDAQ: BLFS) EVP has 516 shares withheld for taxes

Mathew Aby J., EVP & Chief Scientific Officer of BioLife Solutions (NASDAQ: BLFS), reported a tax-withholding disposition of 516 shares of common stock on July 7, 2026. The shares, valued at $27.79 each, were withheld by the company to cover tax obligations arising from the relea

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

BioLife Solutions (BLFS) CFO has 844 shares withheld for RSU taxes

BioLife Solutions' CFO, Troy Wichterman, had 844 shares of common stock withheld by the company to cover tax obligations arising from the release of restricted stock units. This transaction, valued at $27.79 per share, was a tax-withholding disposition and not an open market sale

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 21:09
Source
Stock Titan
Simply Wall Street Direct company coverage

3 Stocks That May Be Trading At A Discount Of Up To 45.8% Below Intrinsic Value Estimates

This article identifies three U.S. stocks—BioLife Solutions (BLFS), Mission Produce (AVO), and OceanFirst Financial (OCFC)—that are estimated to be trading below their intrinsic values based on future cash flow. Each company's operations, estimated discount, and growth forecasts

Tone
Positive 72/100
Event
Balance sheet
Published
13 Jul 2026 17:09
Source
Simply Wall Street
Simply Wall Street Direct company coverage

How Broad Russell Value Index Inclusion Will Impact BioLife Solutions (BLFS) Investors

BioLife Solutions (BLFS) was recently added to several Russell value-oriented indices, including the Russell 2000 Value. This inclusion is expected to boost the company's visibility among institutional investors and increase liquidity, though it doesn't alter the fundamental near

Tone
Positive 65/100
Event
Balance sheet
Published
07 Jul 2026 16:12
Source
Simply Wall Street
Finviz Direct company coverage

BLFS - Biolife Solutions Inc Options

This article provides comprehensive financial data and stock performance metrics for Biolife Solutions Inc. (BLFS), including its last close price, market capitalization, income, sales, key financial ratios, EPS, and insider/institutional ownership details. It also features vario

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 22:41
Source
Finviz
GuruFocus Direct company coverage

Q3 2025 BioLife Solutions Inc Earnings Call Transcript

BioLife Solutions Inc. reported strong Q3 2025 results with a 33% year-over-year increase in cell processing revenue and a 31% increase in total revenue. The company raised its full-year 2025 revenue guidance and improved its balance sheet with a $25 million sale, leading to adju

Tone
Positive 67/100
Event
Earnings
Published
02 Jul 2026 10:12
Source
GuruFocus
Simply Wall Street Direct company coverage

Does BioLife Solutions’ (BLFS) Russell Value Index Debut Recast Its Cell and Gene Therapy Narrative?

BioLife Solutions (BLFS) was recently added to several Russell value-oriented indices, which is expected to increase its visibility among institutional investors. This inclusion, however, does not alter the company's core strategy of converting embedded products into recurring re

Tone
Positive 67/100
Event
Market update
Published
30 Jun 2026 11:10
Source
Simply Wall Street
marketscreener.com Direct company coverage

BioLife Solutions, Inc.(NasdaqCM:BLFS) added to Russell Microcap Value Benchmark Index

BioLife Solutions, Inc. (NasdaqCM:BLFS), a developer and supplier of cell processing tools and services for the cell and gene therapy market, has been added to the Russell Microcap Value Benchmark Index. The company provides solutions like CryoStor freeze media and HypoThermosol

Tone
Positive 71/100
Event
Market update
Published
29 Jun 2026 12:57
Source
marketscreener.com
www.marketscreener.com Direct company coverage

BioLife Solutions, Inc.(NasdaqCM: BLFS) added to Russell 2000 Value Benchmark

BioLife Solutions, Inc. (NasdaqCM: BLFS) has been added to the Russell 2000 Value Benchmark Index, as announced on June 29, 2026. This news follows the company's recent addition to the Russell Microcap Value Benchmark Index. The article also provides recent financial performance,

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 11:41
Source
www.marketscreener.com
Simply Wall Street Direct company coverage

BioLife Solutions (BLFS) Joins Multiple Russell Value Indexes At Once

BioLife Solutions (BLFS) has been included in several Russell Value Benchmark indexes, a development likely to influence institutional and index-tracking funds' approach to the stock. The company's shares have shown strong short-term momentum with a 15.0% return over the past mon

Tone
Positive 73/100
Event
Market update
Published
29 Jun 2026 10:41
Source
Simply Wall Street
TradingView Direct company coverage

Price to earnings forward of BioLife Solutions, Inc. – NASDAQ:BLFS

This article provides financial information for BioLife Solutions, Inc. (NASDAQ: BLFS), focusing on its price-to-earnings forward metric. The content highlights the company's financial data, market performance on Nasdaq, and general overview within the health technology sector.

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 08:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of BioLife Solutions, Inc. – NASDAQ:BLFS

This article focuses on the enterprise value to EBITDA forward for BioLife Solutions, Inc. (NASDAQ: BLFS). It appears to be a financial data snippet from TradingView, indicating a period, value, and change associated with this financial metric.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 22:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of BioLife Solutions, Inc. – NASDAQ:BLFS

This article provides financial information for BioLife Solutions, Inc. (NASDAQ: BLFS), specifically focusing on its enterprise value to forward revenue. It highlights that this data and other financial metrics are available on TradingView, which serves as a platform for market d

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 18:09
Source
TradingView
Investing.com Direct company coverage

Biolife Solutions stock hits 52-week high at 29.67 USD

BioLife Solutions Inc. (BLFS) stock reached a new 52-week high of $29.67, with its current trading price at $29.77 and a market capitalization of $1.44 billion. The company has seen a 32.53% increase in stock value over the past year and reported impressive Q1 2026 earnings with

Tone
Positive 72/100
Event
Earnings
Published
27 Jun 2026 08:40
Source
Investing.com
TradingView Direct company coverage

BioLife Solutions, Inc. Actuals & Estimates (SWB:BJX1)

This article provides detailed financial actuals and analyst estimates for BioLife Solutions, Inc. (SWB: BJX1), covering income statements, balance sheets, cash flow, and valuation metrics. It highlights future price predictions, historical price records, upcoming earnings report

Tone
Positive 64/100
Event
Earnings
Published
27 Jun 2026 07:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of BioLife Solutions, Inc. – LSX:A1XCF2

The article provides financial information for BioLife Solutions, Inc. (A1XCF2) on the Lang & Schwarz Exchange, specifically focusing on its price-to-book forward metric. It appears to be a stub or a section from a larger financial data platform, indicating key financial data poi

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 04:11
Source
TradingView
TradingView Direct company coverage

BioLife Solutions, Inc. Actuals & Estimates (LS:A1XCF2)

This article provides an overview of BioLife Solutions, Inc. (A1XCF2) 's financial actuals and estimates, including its current stock price, market capitalization, earnings, and revenue. It details analyst forecasts, historical price performance, and key financial metrics like EB

Tone
Positive 66/100
Event
Earnings
Published
27 Jun 2026 00:40
Source
TradingView
TradingView Direct company coverage

BioLife Solutions, Inc. Actuals & Estimates (NASDAQ:BLFS)

This article provides key financial actuals and estimates for BioLife Solutions, Inc. (BLFS), including its current stock price, historical performance, analyst forecasts, and recent earnings data. It highlights the company's valuation metrics, revenue, net income, and market cap

Tone
Positive 71/100
Event
Earnings
Published
25 Jun 2026 23:10
Source
TradingView
TradingView Direct company coverage

BLFS Forecast — Price Target — Prediction for 2027

BioLife Solutions, Inc. (BLFS) stock currently trades at $27.50, with analysts providing a 1-year price target ranging from $30.00 to $34.00, and a consensus target of $32.30. The company has seen significant stock increases in the past year and expects its next earnings report o

Tone
Positive 70/100
Event
Guidance
Published
25 Jun 2026 16:10
Source
TradingView
Stock Traders Daily Direct company coverage

Behavioral Patterns of BLFS and Institutional Flows

Biolife Solutions Inc. (NASDAQ: BLFS) is showing weak near and mid-term sentiment, with a neutral long-term outlook. An exceptional 44.4:1 risk-reward short setup is identified, targeting a 13.4% downside with only 0.3% risk. AI models have generated three trading strategies: a L

Tone
Negative 40/100
Event
Guidance
Published
25 Jun 2026 03:41
Source
Stock Traders Daily
Stock Titan Direct company coverage

BioLife Solutions (BLFS) CFO reports 937-share tax withholding, holds 214K shares

BioLife Solutions CFO Troy Wichterman had 937 shares withheld to cover tax obligations related to the release of restricted stock units. This transaction, valued at $26.04 per share, was a routine tax settlement, not an open-market sale. After the withholding, Wichterman directly

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 20:09
Source
Stock Titan
Investing.com South Africa Direct company coverage

Form 4 BioLife Solutions Inc For: 22 June By Investing.com

This article from Investing.com reports on a Form 4 filing for BioLife Solutions Inc. dated June 22. It indicates the stock symbol BLFS and notes a 3.15% increase. The content appears to be primarily an announcement of the filing rather than an in-depth analysis.

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 06:40
Source
Investing.com South Africa
Stock Titan Direct company coverage

BioLife Solutions (BLFS) CEO reports RSU tax share withholding

BioLife Solutions' President and CEO, Roderick De Greef, had 2,775 shares of common stock withheld by the company to cover tax obligations stemming from the release of restricted stock units. This was a non-market transaction for tax purposes, not a sale. Following this withholdi

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity

BIOLIFE SOLUTIONS INC's Chief Technology Officer, Sean Werner, reported a disposition of 420 shares of Common Stock at $26.04 per share. This transaction was not an open-market trade but shares withheld by the company to cover tax withholding obligations related to restricted sto

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

BioLife Solutions (BLFS) CMO has 470 shares withheld to cover RSU tax bill

BioLife Solutions' Chief Marketing Officer, Todd Berard, had 470 shares of common stock withheld by the company to cover tax obligations related to the vesting of his restricted stock units (RSUs). This transaction, which is a tax-withholding disposition and not an open-market sa

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:41
Source
Stock Titan
Simply Wall Street Direct company coverage

BioLife Solutions (BLFS) Stock Could Be 19.7% Undervalued After Portfolio Re Entry

BioLife Solutions (BLFS) has been re-added to Prosper Stars & Stripes' portfolio, highlighting its focus on biopreservation and cell/gene therapy. The stock has seen significant short-term gains, with analysts suggesting it could be 19.7% undervalued at $32.44 compared to its cur

Tone
Positive 64/100
Event
Market update
Published
22 Jun 2026 07:10
Source
Simply Wall Street